Nalini Singh, MD, MPH

Nalini Singh, MD, MPHNalini Singh, MD, MPH is Professor of Pediatrics, Epidemiology and Global Health in the Schools of Medicine and Health Care Sciences, and Public Health, The George Washington University, Washington, D.C. Dr. Singh was Chair of the Division of Infectious Diseases at Children's National from July 2000 to June 2012 and has worked for over three decades in infectious diseases and infection prevention. She was a member of Healthcare Infection Control Practices Advisory Committee from 2003-2008 and participated in the development of guidelines for prevention of transmission of multi-drug resistant organisms.

Sarah Haessler, MD

Dr. Haessler is the Hospital Epidemiologist and a faculty member in the division of Infectious Diseases at Baystate Medical Center in Springfield Massachusetts, and an Assistant Professor of Medicine at Tufts University School of Medicine. In addition, she oversees infection control at 5 community hospitals in the Western Massachusetts region.

She received her medical degree at the George Washington University School of Medicine and completed her medicine and infectious diseases fellowship training at Dartmouth Hitchcock Medical Center.

Dr. Daniel Diekema

Dr. Daniel Diekema is the 2014 SHEA President of the SHEA Board of Trustees and is a Professor of Internal Medicine and Pathology, and Director of the Infectious Diseases Division at the University of Iowa Carver College of Medicine. He also serves as associate director of the University of Iowa Hospital Clinical Microbiology Laboratory, and the associate hospital epidemiologist at University of Iowa Healthcare. Dr. Diekema’s clinical and research interests include the role of the microbiology laboratory in infection prevention, the epidemiology of invasive fungal infections in hospitalized patients, and the epidemiology of antimicrobial resistance. He has authored or co-authored over 200 peer-reviewed publications and 12 book chapters in these areas of interest.

Dr. Lisa Maragakis, MD, MPH

Dr. Lisa Maragakis, MD, MPH Dr. Maragakis is the Hospital Epidemiologist and Director of the Department of Hospital Epidemiology and Infection Control at The Johns Hopkins Hospital, and is an Assistant Professor of Medicine at The Johns Hopkins University.

She received her medical degree and post-doctoral Infectious Diseases training at The Johns Hopkins University School of Medicine and a master’s degree in public health from The Johns Hopkins University Bloomberg School of Public Health.

Dr. Erik R. Dubberke, MD, MSPH

Dr. Dubberke is an Associate Professor of Medicine at Washington University School of Medicine in St. Louis, where he has been a faculty member in the Division of Infectious Diseases since 2005. He is an Associate Hospital Epidemiologist at Barnes-Jewish Hospital, Medical Director of Infection Control at Missouri Baptist Medical Center, and is the Director of the Section of Transplant Infectious Diseases at Washington University.

He attended medical school at University of Illinois at Chicago, and did his medicine and infectious diseases training at Barnes-Jewish Hospital/Washington University. He received a Master’s of Science in Public Health from St. Louis University.

Scott K. Fridkin, MD

Scott K. Fridkin, MD, is currently deputy branch chief of the surveillance branch in the Division of Healthcare Quality Promotion (DHQP), National Center for Emerging and Zoonotic Infectious Diseases, CDC. He attended medical school at Loyola University Stritch School of Medicine, and completed his residency at The University of Minnesota Hospital and Clinics. Dr. Fridkin spent two years training as an epidemic intelligence officer at the CDC in the Hospital Infections Program before completing a Fellowship in Infectious Diseases at Rush-Presbyterian-St. Luke’s Medical Center and Cook County Hospital in Chicago, Illinois.

Vikas Manchanda, MD

Dr. Vikas Manchanda received his clinical microbiology training at University College of Medical Sciences New Delhi, India. Currently, he is Head of Clinical Microbiology and Infectious Diseases at Chacha Nehru Bal Chikitsalaya (CNBC) and associated Maulana Azad Medical College, Delhi, India. He is heading surveillance and infection control division at CNBC and is secretary of Hospital Infection control committee. He is also head of Quality Management Division and has been instrumental in getting his hospital NABH accredited, making it first public sector hospital in country to achieve this milestone.

Kris Bryant, MD

Dr. Kris Bryant is the hospital epidemiologist at Kosair Children's Hospital and member of the leadership team that oversees infection prevention and control efforts at Norton Healthcare in Louisville, KY.

She serves as a member of the Kentucky-State Regional Infection Prevention and Epidemiology (K-STRIPE) Advisory Committee, a group of professionals from different health care fields dedicated to preventing healthcare-associated infections. She is an Associate Professor of Pediatrics at the University of Louisville School of Medicine, where she directs the Kosair Charities Pediatric Infectious Diseases Fellowship program.

Kavita K. Trivedi, MD

Dr. Kavita K. Trivedi is the Public Health Medical Officer of the Healthcare Associated Infections Program at the California Department of Public Health (CDPH).

As a medical epidemiologist, Dr. Trivedi created, manages and leads the California Antimicrobial Stewardship Program Initiative. This initiative assists California hospitals and long-term care facilities implement and strengthen antimicrobial stewardship programs. She also leads CDPH in investigating outbreaks, potential exposures and enquiries regarding infection control and prevention in healthcare settings. Dr. Trivedi currently serves as the Chair of the SHEA Education Committee.

Stephen G. Weber, MD, MPH

Dr. Stephen G. Weber is the Chief Medical Officer and Vice President for Clinical Effectiveness at the University of Chicago Medicine. He is an Associate Professor in the Section of Infectious Diseases and Global Health.

Dr. Weber received his MD from the New York University School of Medicine and performed his residency in Internal Medicine at the University of Chicago, where he also served as Chief Medical Resident. He completed his subspecialty fellowship in Infectious Diseases at the Beth Israel Deaconess Medical Center in Boston, where he also received a Master’s Degree in Epidemiology from the Harvard School of Public Health.

Mary Hayden, MD

Mary Hayden, MD is a specialist in infectious diseases, professor of medicine (infectious diseases) and pathology, and director of the clinical microbiology laboratory at Rush University Medical Center in Chicago, IL.

Dr. Hayden's research interests include prevention of healthcare-associated infections, especially those caused by antibiotic-resistant bacteria.

Trevor Van Schooneveld, MD

Dr. Trevor Van Schooneveld is an Assistant Professor in the Division of Infectious Disease, Department of Internal Medicine at the University of Nebraska Medical Center. He is currently the chair of SHEA Journal Club committee and serves on the Publications committee. Dr. Van Schooneveld is the Medical Director of the Antimicrobial Stewardship Program at the Nebraska Medical Center and Associate Medical Director of the Department of Infection Control and Epidemiology.

He attended medical school at the University of Nebraska Medical Center, where he also completed his internship and residency in Internal Medicine, and served as Chief Resident. His fellowship training in Infectious Disease was completed at Creighton University Medical Center.

Deborah S. Yokoe, MD, MPH

Dr. Yokoe is the Hospital Epidemiologist and Medical Director of the Infection Control Department and a member of the Infectious Diseases Division at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, and is an Associate Professor of Medicine at Harvard Medical School. She currently serves as a SHEA Councilor and SHEA Education & Research Foundation board member and is a member of the SHEA Research Committee.

She continues to be the SHEA co-lead for the updating of “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals”. She is also currently a member of the CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC) and is a CDC Prevention Epicenters investigator.

John A. Jernigan, M.D., M.S

John A. Jernigan, M.D., M.S. is currently Director of the Office of Prevention Research and Evaluation, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention(CDC), and Clinical Associate Professor of Medicine at the Emory University School of Medicine, Division of Infectious Diseases. He attended medical school at Vanderbilt University, where he also completed his internship and residency in Internal Medicine, and served as Chief Medical Resident.

Louise M. Dembry, MD, MS, MBA

Dr. Louise Dembry is a member of the SHEA Board and the outgoing Treasurer. She has served on the SHEA Board for the past three years and participated in the creation of the SHEA Education and Research Foundation (ERF) during that time. She will continue to serve on the SHEA ERF Board for the next year. Dr. Dembry joined SHEA in 1993 as an Infectious Diseases Fellow and has served on various SHEA committees and task forces including chairing the Publications Committee 2007-1010 and the Scientific Program for the 2004, participated in several review groups and served as faculty for the SHEA/CDC course for many years and the more recent HAI Regional Training program.

Kerri A Thom, MD, MS

Kerri A Thom, MD, MS, is an infectious disease physician and assistant professor in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine, Baltimore. She is also Associate Hospital Epidemiologist at the University of Maryland Medical Center. Dr. Thom's research interests include the epidemiology and transmission of multidrug-resistant gram negative pathogens, antimicrobial resistance and infection prevention.

She has a particular interest in Acinetobacter baumannii and is currently supported by an NIH K23 award to study the epidemiology of this pathogen in the healthcare setting.

William A. Rutala, Ph.D., M.P.H

Dr. Bill Rutala is a Professor for the Division of Infectious Diseases at the University of North Carolina's School of Medicine, and serves as the Director of Hospital Epidemiology, Occupational Health and Safety Program at the University of North Carolina Health Care System. He is also Director and co-founder of the Statewide Program for Infection Control and Epidemiology at the UNC School of Medicine and a retired Colonel with the U.S. Army Reserve. Dr. Rutala is certified in infection control. He has 500 publications in the fields of infectious diseases, infection control, disinfection, sterilization and medical waste to include several guidelines and has also been an invited lecturer at over 300 state, national and international conferences (in over 40 states and 25 countries) and has testified twice before the U.S. Congress.

Dr. Tara Palmore

Dr. Palmore is an infectious diseases specialist and Deputy Hospital Epidemiologist at the National Institutes of Health Clinical Center. In her clinical role, she serves as an infectious diseases consultant in the Clinical Center, which has a large stem cell transplantation program and other categories of heavily immunosuppressed patients. Dr. Palmore did her undergraduate education at Harvard College and attended the University of Virginia School of Medicine. She completed internal medicine residency at the New York Presbyterian Hospital/Cornell and infectious diseases fellowship at the National Institute of Allergy and Infectious Diseases.

Dr. Sharmila Sengupta MD

Dr. Sengupta is a clinical microbiologist, who has been working in infection control and healthcare epidemiology for the last 18 years in India. Though the burden of multi-drug resistant pathogens are very high in India, healthcare epidemiology and infection control are relatively at a nascent stage. She is one of the first Indians to be selected as a SHEA International Ambassador and has been a part of the small working group of clinicians who are working towards capacity building in training infection control nurses and healthcare epidemiologists.

Daniel J Morgan M.D.

Dr. Morgan was a founding member of the SHEA Research Network. In this role, he conducted a study examining the effect of CMS non-payment policy for CAUTIs that is in press at Clinical Infectious Diseases. He encourages those not members of the SHEA Research Network to Join (completing a short survey ).

In Baltimore, MD, Dr. Morgan is an infectious disease physician and hospital epidemiologist at the University of Maryland School of Medicine and VA Maryland Healthcare System.